317 related articles for article (PubMed ID: 19888600)
1. Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice.
Chen K; Northington FJ; Martin LJ
Brain Struct Funct; 2010 Mar; 214(2-3):219-34. PubMed ID: 19888600
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Almer G; Vukosavic S; Romero N; Przedborski S
J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851
[TBL] [Abstract][Full Text] [Related]
3. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.
Martin LJ; Liu Z; Chen K; Price AC; Pan Y; Swaby JA; Golden WC
J Comp Neurol; 2007 Jan; 500(1):20-46. PubMed ID: 17099894
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration.
Martin LJ
Rev Neurosci; 2007; 18(2):115-36. PubMed ID: 17593875
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice.
Martin LJ; Gertz B; Pan Y; Price AC; Molkentin JD; Chang Q
Exp Neurol; 2009 Aug; 218(2):333-46. PubMed ID: 19272377
[TBL] [Abstract][Full Text] [Related]
6. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.
Lewis KE; Rasmussen AL; Bennett W; King A; West AK; Chung RS; Chuah MI
J Neuroinflammation; 2014 Mar; 11():55. PubMed ID: 24655927
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice.
Lee J; Ryu H; Kowall NW
Biochem Biophys Res Commun; 2009 Sep; 387(1):202-6. PubMed ID: 19580782
[TBL] [Abstract][Full Text] [Related]
8. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
9. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice.
Valsecchi V; Boido M; Montarolo F; Guglielmotto M; Perga S; Martire S; Cutrupi S; Iannello A; Gionchiglia N; Signorino E; Calvo A; Fuda G; Chiò A; Bertolotto A; Vercelli A
Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32188741
[TBL] [Abstract][Full Text] [Related]
11. Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation.
Martin LJ; Chen K; Liu Z
J Neurosci; 2005 Jul; 25(27):6449-59. PubMed ID: 16000635
[TBL] [Abstract][Full Text] [Related]
12. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
13. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Gento-Caro Á; Vilches-Herrando E; Portillo F; González-Forero D; Moreno-López B
Brain Pathol; 2022 May; 32(3):e13022. PubMed ID: 34585475
[TBL] [Abstract][Full Text] [Related]
14. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
Turner BJ; Ackerley S; Davies KE; Talbot K
Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901
[TBL] [Abstract][Full Text] [Related]
15. Progressive Degeneration and Inhibition of Peripheral Nerve Regeneration in the SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis.
Deng B; Lv W; Duan W; Liu Y; Li Z; Ma Y; Zhang G; Song X; Cui C; Qi X; Li Y; Li C
Cell Physiol Biochem; 2018; 46(6):2358-2372. PubMed ID: 29742495
[TBL] [Abstract][Full Text] [Related]
16. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
[TBL] [Abstract][Full Text] [Related]
17. Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and α-internexin immunoreactivity.
King AE; Blizzard CA; Southam KA; Vickers JC; Dickson TC
Brain Res; 2012 Jul; 1465():90-100. PubMed ID: 22609817
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase (iNOS) and nitrotyrosine immunoreactivity in the spinal cords of transgenic mice with a G93A mutant SOD1 gene.
Sasaki S; Warita H; Abe K; Iwata M
J Neuropathol Exp Neurol; 2001 Sep; 60(9):839-46. PubMed ID: 11556540
[TBL] [Abstract][Full Text] [Related]
19. Interfering with lysophosphatidic acid receptor edg2/lpa
Gento-Caro Á; Vilches-Herrando E; García-Morales V; Portillo F; Rodríguez-Bey G; González-Forero D; Moreno-López B
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1004-1018. PubMed ID: 33508894
[TBL] [Abstract][Full Text] [Related]
20. Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells.
Keller AF; Gravel M; Kriz J
Glia; 2009 Aug; 57(10):1130-42. PubMed ID: 19115383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
